Page last updated: 2024-08-23

selegiline and Melanoma

selegiline has been researched along with Melanoma in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Augustine, EF; Auinger, P; Constantinescu, R; Elm, J; Khadim, L; Kieburtz, K; Sharma, S	1
Barna, G; Magyar, K; Szende, B	1
Lengyel, J; Magyar, K; Szatmáry, I; Szende, B; Tarczali, J	1
Bocsi, J; Bökönyi, G; Kéri, G; Magyar, K; Szende, B; Timár, F	1

Reviews

1 review(s) available for selegiline and Melanoma

Article	Year
The neuroprotective and neuronal rescue effects of (-)-deprenyl. Journal of neural transmission. Supplementum, 1998, Volume: 52 Topics: Animals; Antiparkinson Agents; Benzylamines; Biotransformation; Brain; Humans; Melanoma; Neurons; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Rats; Selegiline; Tissue Distribution; Tumor Cells, Cultured	1998

Trials

1 trial(s) available for selegiline and Melanoma

Article	Year
Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial. Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Double-Blind Method; Female; Humans; Incidence; Male; Melanoma; Middle Aged; National Institutes of Health (U.S.); Neuroprotective Agents; Parkinson Disease; Selegiline; Skin Neoplasms; United States; Young Adult	2014

Article

Year

Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial.

Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Double-Blind Method; Female; Humans; Incidence; Male; Melanoma; Middle Aged; National Institutes of Health (U.S.); Neuroprotective Agents; Parkinson Disease; Selegiline; Skin Neoplasms; United States; Young Adult

2014

Other Studies

2 other study(ies) available for selegiline and Melanoma

Article	Year
Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells. Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:6 Topics: Amphetamines; Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; Cytoprotection; Drug Interactions; Flow Cytometry; Glutathione; Humans; Melanoma; Monoamine Oxidase Inhibitors; Radiation-Sensitizing Agents; Selegiline; Serum	2010
Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites. Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:1 Topics: Adrenergic Agents; Apoptosis; Caspase 3; Caspases; Cell Survival; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Melanoma; Methamphetamine; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Proadifen; Selegiline; Tumor Cells, Cultured	2001

Article

Year

Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells.

Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:6

Topics: Amphetamines; Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; Cytoprotection; Drug Interactions; Flow Cytometry; Glutathione; Humans; Melanoma; Monoamine Oxidase Inhibitors; Radiation-Sensitizing Agents; Selegiline; Serum

2010

Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites.

Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:1

Topics: Adrenergic Agents; Apoptosis; Caspase 3; Caspases; Cell Survival; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Melanoma; Methamphetamine; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Proadifen; Selegiline; Tumor Cells, Cultured

2001